Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05353478 · ClinicalTrials.gov registry record
Reducing Opioid Prescription After Kidney Stone Removal Surgery
A clinical trial of Kidney Stone, sponsored by Mayo Clinic.
- Active
- Registry status
- 80
- Enrollment target
- 1
- Study location
NCT05353478: Active study of Kidney Stone, sponsored by Mayo Clinic.
NCT05353478 is a study of Kidney Stone that is active but no longer recruiting, run by Mayo Clinic. The registered enrollment target is 80 participants, below the 190-participant average among 28 other Kidney Stone trials with a reported enrollment target (58% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05353478, a study of Kidney Stone, is active but no longer recruiting, sponsored by Mayo Clinic.
- ACTIVE NOT RECRUITING
- Registry status
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to implement and assess a standard way of prescribing opioid pain medication following PCNL (a kidney stone removal surgery) to ensure patients are being discharged with an appropriate quantity of pain management medication.
Primary Outcome
Number of unused opioids following recovery from percutaneous nephrolithotomy
Conditions Studied
Study Locations (1)
Minnesota
- Mayo Clinic Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2022-06-06 |
| Est. Completion | 2026-08 |
What the registry record for NCT05353478 still lists
NCT05353478 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 190-participant average among 28 other Kidney Stone trials with a reported enrollment target (58% lower).
The record links to 1 condition, with Kidney Stone appearing as the primary indexed condition, and to 0 interventions.
NCT05353478 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT05353478 about?
NCT05353478 is a clinical study titled "Reducing Opioid Prescription After Kidney Stone Removal Surgery". The purpose of this study is to implement and assess a standard way of prescribing opioid pain medication following PCNL (a kidney stone removal surgery) to ensure patients are being discharged with an appropriate quantity of pain management medication.
What is the current status of trial NCT05353478?
This trial is currently active not recruiting. The enrollment target is 80 participants. The study started on 2022-06-06. Estimated completion is 2026-08.
What conditions does trial NCT05353478 study?
This clinical trial studies the following conditions: Kidney Stone.
Who is sponsoring clinical trial NCT05353478?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05353478 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Kidney Stone
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05353478's enrollment target sits among peer trials
80 12th of 28 higher than 15 of 28 other Kidney Stone trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Kidney Stone trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Oxalate and Citrate in Humans - Response to Citrate
RECRUITING · NA
-
Gut Oxalate Absorption in Calcium Oxalate Stone Disease
RECRUITING · NA
-
High Powered Stone Dusting vs. Fragmentation and Basketing at Time of Ureteroscopy
RECRUITING · NA
-
Access Sheath and Stent Trial
RECRUITING · NA
-
GI Oxalate Absorption
RECRUITING · NA
-
Evaluation of the LithoVue Elite Ureteroscope With Intra-Renal Pressure Monitoring Technology: Examination of Surgeon Behavior and Post-operative Outcomes
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI